Overview of the global sepsis diagnostics market
One of the major factors responsible for the prevalence of sepsis is the rising cases of hospital-acquired infections (HAI). HAI is also known as the nosocomial infection. Patients can develop HAI during hospitalization or after they are discharged from the hospital due to the presence of viral, bacterial, and fungal pathogens in the hospital environment. HAI can, in turn, lead to septicemia.
Sepsis diagnostics market drivers
Technavio’s market research report identifies that the rising prevalence of HAIs on a global level will be one of the primary growth drivers for the global sepsis diagnostics market till 2021. According to the studies, in China, HAI among people who are admitted to hospitals for the treatment of respiratory tract infection, urinary tract infection, and bloodstream infection is very high.
Also, the surgical site infections (SSI) and pneumonia in hospitals such as teaching hospitals in Ethiopia are also driving the prevalence of HAIs. Similarly, in the US, the incidence of septic shock and severe sepsis is high among the older population who get admitted to hospitals for general surgery or another diagnosis purpose. Technavio’s market research analysts predict that this market will grow at a CAGR of close to 7% by 2021.
Get A Free Sample
Sepsis diagnostics market growth as per regions
A large number of manufacturers and distributors of sepsis diagnostics are headquartered in the US. Also, many companies are setting up many offices in Canada, Mexico, Brazil, and Argentina to boost their market penetration. The organizations and government are introducing many measurements to curb sepsis by increasing the awareness about sepsis. They are also focusing on promoting early recognition of sepsis through infection prevention, chronic disease management, and appropriate antibiotic use. This, in turn, will have a positive impact on the market in the Americas.
Sepsis diagnostics market worth: Competitive landscape and key vendors
The sepsis diagnostics market is characterized by the existence of top manufacturers. Vendors of the sepsis diagnostic tests market are increasingly competing against each other based on factors such as pricing pressure, product performance, capital support for product or technology up gradation, and distribution partnerships, test menus, automation and integration of the products.
Key vendors in the sepsis diagnostics market
Sepsis diagnostics market segmentation by technology
- Immunoassay testing
- Point-of-care testing (POCT)
- molecular testing
The immunoassay testing segment contributed the majority of shares towards the market for sepsis diagnostics market during 2016 due to the increasing number of product launches from various vendors such as Hoffmann-La Roche. Also, the market segment will continue to grow during the estimated period due to the rising application of novel products for the sepsis diagnostics and treatment.
Sepsis diagnostics market segmentation by end-user
- Hospitals and clinics
- Diagnostic laboratories
Manufacturers of sepsis diagnostics are focusing on expanding their product reach and improve brand image by delivering high-quality products to hospitals. Also, hospitals and clinics adopt these advanced products to enhance the efficiency of the treatment. The super-specialty and multispecialty divisions in tier 1 and tier 2 hospitals provide sepsis diagnostic tests and treatment to patients. In addition, these hospitals perform sepsis diagnostics at low costs due to the rising funds from governments.
Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global sepsis diagnostics market?
- What are the key market trends impacting the growth of the global sepsis diagnostics market?
- What are the challenges to market growth?
- Who are the key vendors in the global sepsis diagnostics market?
- What are the market opportunities and threats faced by the vendors in the global sepsis diagnostics market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global sepsis diagnostics market?
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research methodology
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Market segmentation by technology
- Market overview
- Immunoassay testing
- POCT
- Molecular testing
PART 07: Market segmentation by end-user
- Market overview
- Hospital and clinics
- Diagnostic laboratories
PART 08: Geographical segmentation
- Sepsis diagnostics market in Americas
- Sepsis diagnostics market in EMEA
- Sepsis diagnostics market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
- Market drivers
- Market challenges
PART 11: Market trends
- Development of novel products
- Increasing use of biomarkers for sepsis
- Increasing online campaigns for sepsis awareness
PART 12: Vendor landscape
PART 13: Key vendors
- bioMérieux
- T2 Biosystems
- Key companies to watch
- Other prominent vendors
- List of abbreviations
PART 14: Appendix